Kevetrin hydrochloride,
66592-89-0,
KEVETRIN,
Kevetrin (hydrochloride),
UNII-NL6L2371DP,
Kevetrin Hcl,
4-Isothioureidobutyronitrile hydrochloride,
NL6L2371DP,
500863-50-3,
NSC 525990,
kevetrin-hydrochloride,
Thioureidobutyronitrile HCl,
SCHEMBL851612,
EX-A627,
Carbamimidothioic acid, 3-cyanopropyl ester, monohydrochloride,
BCP16345,
MFCD22572767,
thioureido butyronitrile hydrochloride,
AKOS027439952,
CS-4976,
AK499423,
HY-16271,
FT-0700349,
A13797,
4-(carbamimidoylsulfanyl)butanenitrile hydrochloride,
J-690340,
(2E,6E)-2,6-Bis(4-pyridinylmethylene)-cyclohexanone,
Carbamimidothioic acid,3-cyanopropyl ester,hydrochloride,
CarbaMiMidothioic acid, 3-cyanopropyl ester, hydrochloride (1,
kevetrin.HCl,
thioureidobutyronitrile,
D0K7DV,
4-Isothioureidobutyronitrile,
UNII-C3059TG1KN,
2-(3-cyanopropyl)isothiourea,
NSC-525990,
66592-89-0 (HCl),
Carbamimidothioic acid, 3-cyanopropyl ester,
LBT4/angiogenesis inhibitor (cancer), Cellceutrix,
CarbaMiMidothioic acid, 3-cyanopropyl ester, hydrochloride (1:1),